A detailed history of Headlands Technologies LLC transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Headlands Technologies LLC holds 16,442 shares of RVMD stock, worth $724,434. This represents 0.09% of its overall portfolio holdings.

Number of Shares
16,442
Holding current value
$724,434
% of portfolio
0.09%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$36.92 - $47.94 $607,038 - $788,229
16,442 New
16,442 $744,000
Q1 2024

May 07, 2024

BUY
$26.56 - $33.55 $23,505 - $29,691
885 Added 140.92%
1,513 $48,000
Q4 2023

Feb 02, 2024

BUY
$18.35 - $34.12 $11,523 - $21,427
628 New
628 $18,000

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $3.86B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Headlands Technologies LLC Portfolio

Follow Headlands Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headlands Technologies LLC with notifications on news.